Immatics NV (IMTX)
8.50
-0.07
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
8.50
0.00 (0.00%)
After-Hours: 18:16
Immatics Total Liabilities (Quarterly): 256.27M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 256.27M |
| March 31, 2024 | 272.50M |
| December 31, 2023 | 314.91M |
| September 30, 2023 | 200.80M |
| June 30, 2023 | 208.63M |
| March 31, 2023 | 194.54M |
| December 31, 2022 | 208.75M |
| September 30, 2022 | 237.12M |
| June 30, 2022 | 254.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 185.49M |
| December 31, 2021 | 170.49M |
| September 30, 2021 | 189.93M |
| June 30, 2021 | 166.68M |
| March 31, 2021 | 168.91M |
| December 31, 2020 | 205.72M |
| September 30, 2020 | 189.46M |
| June 30, 2020 | 197.86M |
| December 31, 2019 | 196.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
166.68M
Minimum
Jun 2021
314.91M
Maximum
Dec 2023
212.13M
Average
199.33M
Median
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 26.22M |
| InflaRx NV | 11.66M |
| BioNTech SE | 3.671B |
| CureVac NV | 193.27M |
| ATAI Life Sciences NV | 47.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 672.05M |
| Shareholders Equity (Quarterly) | 415.78M |
| Current Ratio | 3.739 |